InformAI
3 known investors
InformAI builds AI-driven enterprise software for clinical use in radiology, radiation oncology, and high-acuity informatics, including RadOncAI for radiation therapy dose planning, TransplantAI for donor-recipient transplant decisions, and SinusAI for CT imaging diagnostics. Its flagship RadOncAI is an FDA 510(k)-cleared software-as-a-medical-device serving medical institutions.
Investors · 3
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase ISTTR | 2020 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does InformAI do?
- InformAI builds AI-driven enterprise software for clinical use in radiology, radiation oncology, and high-acuity informatics, including RadOncAI for radiation therapy dose planning, TransplantAI for donor-recipient transplant decisions, and SinusAI for CT imaging diagnostics. Its flagship RadOncAI is an FDA 510(k)-cleared software-as-a-medical-device serving medical institutions.
- Who are InformAI's investors?
- InformAI's investors include Joyance Partners, Social Starts, DEFTA Partners.